GAiT.Global – The Global Alliance for iPSC Therapies

Achieve consensus on donor selection and screening criteria and consent standards.
Achieve global consensus on manufacturing and quality parameters and standards required to consider an iPSC line to be of clinical grade and develop an external quality assurance scheme to facilitate the development of comparability between centres.
Gain agreement with regulators in various jurisdictions as to the acceptability of the quality standards proposed.
Develop a database of clinical grade iPSC lines.

GAiT will be speaking at the 'Translation and Innovation in induced Pluripotent Stem Cell Science' Workshop at Saïd Business School, Oxford on the 11th February 2020 and at the RESTORE meeting in Berlin on the 17th February 2020.

Reply on Twitter 1222585360066269185 Retweet on Twitter 1222585360066269185 Like on Twitter 1222585360066269185 Twitter 1222585360066269185

Retweet on Twitter GAiT Retweeted

Alexey Bersenev @cells_nnm·

28 Jan 1222152745995722753

Osaka University transplants iPS cell-based heart cells in world's first clinical trial

Osaka University transplants iPS cell-based heart cells in world's first clinical trial | The Japan Times

An Osaka University team said it has carried out the world's first transplant of cardiac muscle cells created from iPS cells in a physician-initiated ...

www.japantimes.co.jp

Reply on Twitter 1222152745995722753 Retweet on Twitter 122215274599572275313 Like on Twitter 122215274599572275326 Twitter 1222152745995722753

GAiT @IPSCtherapies·

23 Jan 1220460524623867904

Reply on Twitter 1220460524623867904 Retweet on Twitter 1220460524623867904 Like on Twitter 12204605246238679041 Twitter 1220460524623867904

Retweet on Twitter GAiT Retweeted

Alexey Bersenev @cells_nnm·

2 Jan 1212524788050223106

Who would have thought 5 years ago that GSK, BMS, Gilead, Pfizer, Roche, J&J, Takeda, Astellas, Vertex... - will become the major cell-gene therapy companies? The craze for acquisitions will continue in 2020. Pharma/Biotech will eat them all!

Reply on Twitter 1212524788050223106 Retweet on Twitter 121252478805022310614 Like on Twitter 121252478805022310651 Twitter 1212524788050223106

GAiT @IPSCtherapies·

13 Dec 1205559188375646208

Thanks to all who participated in the iPSC Quality Round Data Discussion calls this week! Minutes will be sent out Monday.

Reply on Twitter 1205559188375646208 Retweet on Twitter 1205559188375646208 Like on Twitter 12055591883756462082 Twitter 1205559188375646208

GAiT @IPSCtherapies·

13 Dec 1205400495122198528

A Quality Round update was just sent to Participants. We remind those doing retests to upload the data template sheets in addition to raw data.

Reply on Twitter 1205400495122198528 Retweet on Twitter 1205400495122198528 Like on Twitter 12054004951221985281 Twitter 1205400495122198528

Retweet on Twitter GAiT Retweeted

BioInformant @StemCellMarket·

1 Dec 1201260084384415744

Tokyo's Heartseed reaps $26M to test its iPS cell injections for heart failure - The company forms spherical clusters of heart cells from purified, allogeneic iPSCs, which are injected into the heart muscle wall.

https://www.fiercebiotech.com/medtech/tokyo-s-heartseed-reaps-26m-to-test-its-stem-cell-injections-for-heart-failure

Reply on Twitter 1201260084384415744 Retweet on Twitter 12012600843844157447 Like on Twitter 120126008438441574410 Twitter 1201260084384415744

GAiT @IPSCtherapies·

9 Dec 1204065286028242945

We are very grateful for @NIBSC_MHRA, @MCRI_for_kids, @yposkesi, @nyscf, @Inserm, and @cmrb for joining the first two Quality Round data discussion calls today. Your comments and feedback have been documented.

Reply on Twitter 1204065286028242945 Retweet on Twitter 1204065286028242945 Like on Twitter 12040652860282429452 Twitter 1204065286028242945

GAiT @IPSCtherapies·

4 Dec 1202220815976161281

GAiT just sent an iPSC Quality Round Update to Participants from 18 sites across 11 countries informing them of the status of Quality re-tests, the data workshop, and manuscript preparation.

Reply on Twitter 1202220815976161281 Retweet on Twitter 1202220815976161281 Like on Twitter 12022208159761612811 Twitter 1202220815976161281

Retweet on Twitter GAiT Retweeted

BioInformant @StemCellMarket·

1 Dec 1201260486626611200

Kyoto University seeks government approval to conduct a clinical trial of transplanted cartilage made from iPS cells -

Kyoto Univ. seeks to use stem cells for damaged knee joint treatment

Kyoto University says it has asked for government approval to conduct a clinical trial of transplanting cartilage made from induced pluripotent stem c...

english.kyodonews.net

Reply on Twitter 1201260486626611200 Retweet on Twitter 120126048662661120010 Like on Twitter 120126048662661120010 Twitter 1201260486626611200

Welcome to GAiT

About Us

our mission

Our Objectives

News & Events

Main Content

Welcome to GAiT

About Us

our mission

Our Objectives

News & Events

Invite Users to Site

Social media

Newsletter